Soc. Generale Knock-Out GSK/ DE000SW3CYF0 /
03/06/2024 13:27:03 | Chg.- | Bid09:46:12 | Demandez à09:46:12 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
4.05EUR | - | 4.01 Bid taille: 8,000 |
4.02 Ask la taille: 8,000 |
Gsk PLC ORD 31 1/4P | 12.5719 GBP | 31/12/2078 | Call |
GlobeNewswire
10:00
HashiCorp brings The Infrastructure Cloud to Europe and expands Infrastructure and Security Lifecycl...
GlobeNewswire
10:00
FSLY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fastly, Inc. Investors with Su...
GlobeNewswire
10:00
PERI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Perion Network Ltd. Investors ...
GlobeNewswire
10:00
AXTI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AXT Inc Investors with Substan...
GlobeNewswire
10:00
HRBR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Harbor Diversified, Inc. Inves...
GlobeNewswire
10:00
VSTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Vestis Corporation Investors w...
GlobeNewswire
10:00
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with ...
GlobeNewswire
10:00
IG Group Has Fully Integrated the Relay42 Customer Data Platform to Power Customer Acquisition and P...
GlobeNewswire
09:30
NewHydrogen CEO Steve Hill Discusses Challenges of Translating Cutting-edge Science into Marketable ...
GlobeNewswire
09:00
NXP and ZF Collaborate on SiC-Based Traction Inverters to Boost Electric Vehicle Powertrains
GlobeNewswire
09:00
World of Dypians Wins the BNB Chain DAU Incentive Program, Securing $60,000 in BNB
GlobeNewswire
09:00
ExeVir Bio Announces Exceptional Virus Neutralization Potency of its Variant-proof XVR013m Antibody ...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page